About

We have the means to protect everyone from high-risk HPV infections and the cancers they cause.

A more ambitious, ethical and equitable approach to HPV vaccination is needed at the global and national levels.

HPV-related diseases affect millions worldwide, irrespective of sex or gender. HPV can cause a range of cancers – cervical, anal, penile, vaginal, vulval, head and neck – as well as genital warts and recurrent respiratory papillomatosis (RRP). Yet gender-neutral HPV vaccination, despite its numerous benefits, been implemented in only about 70 countries. In almost all middle and low income countries with an HPV vaccination programme, girls alone are vaccinated.

Global Action on Men’s Health and NOMAN is an Island: Race to End HPV Campaign and Global Action on Men’s Health, are two organisations dedicated to promoting health and well-being on a global scale. Together, they are embarking on a mission to ensure global universal access to gender-neutral HPV vaccination, a vital step towards a healthier future for all.

By focusing only on the vaccination of girls to prevent cervical cancer, girls-only programmes fail to protect males sufficiently from the cancers caused by HPV. They also fail to protect unvaccinated women from infection by men, a particular problem in countries with low vaccination rates in girls. Girls-only programmes also mean that they unfairly shoulder the responsibility for prevention. With vaccine supply increasing, single-dose programmes changing cost-effectiveness calculations and new evidence showing that 21% of males have a high-risk (cancer-causing) HPV infection, it is time to make gender-neutral HPV vaccination a global policy and priority.

Through this call for global gender-neutral HPV vaccination, we are not only safeguarding the health of current generations, male and female, but also paving the way for a future where HPV-related cancers and diseases are relics of the past.

This initiative was launched by Global Action on Men’s Health and NOMAN is an Island: Race to End HPV at the World Cancer Congress in Geneva on 19 September 2024. If you missed the live event you can watch ‘Boys, men and HPV the case for worldwide gender neutral vaccination’, and learn about our vision for a HPV cancer free future.

End HPV Global is a partnership between two leading health initiatives

GAMH brings together organisations worldwide around men's health advocacy, working toward a world where every all men and boys have the opportunity to achieve their best possible health, regardless of location or background.

Founded by three siblings after losing their mother to HPV-caused cancer, NOMAN advocates, educates, and builds coalitions worldwide, urging policymakers that gender-neutral HPV vaccination is the only path to elimination.